To the Editor We read with interest the article by Cronberg et al1 in which cognitive function was assessed in survivors of cardiac arrest following targeted management regimens with goal temperatures of either 33°C or 36°C. Using a cohort of 455 survivors enrolled in the targeted temperature management trial,2 it was concluded that no significant difference was found in measures of cognitive performance between the 2 groups.
Deal NS, Schock RB, Peacock WF. Targeted Temperature Management for Cardiac Arrest. JAMA Neurol. 2015;72(9):1076. doi:10.1001/jamaneurol.2015.1372
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.